The Boom That Built Billion-Dollar Empires GLP-1 drugs have reshaped the pharmaceutical landscape, turning obesity and ...

President Donald Trump married two of his biggest campaign promises Thursday by unveiling a most-favored-nation pricing deal for a popular drug used in in vitro fertilization treatments.

Eli Lilly stock dips after missing a priority voucher and price cut talks on rival obesity drugs. Read more here.

Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer its in vitro fertilization (IVF) treatments at a sharp discount on the government's DTC platform TrumpRx.

CMS Administrator Mehmet Oz clarified that a deal has not yet been sealed with the manufacturer of semaglutide, Novo Nordisk, ...

Trump told reporters late Thursday that the list price of Ozempic, which he called “the fat loss drug,” will be “much lower.” ...

Trump and EMD Serono strike a deal to cut fertility drug costs, expand U.S. manufacturing, and launch the TrumpRx Fertility ...

As a caregiver who watched prescription drug prices drain both our wallet and peace of mind, I know firsthand why Congress ...

Merck KGaA has become the third pharma company to reach an agreement with the Trump administration to cut the cost of some of ...

The FDA has named the first products to take advantage of its recently announced Commissioner's national priority voucher ...

During a press conference, Trump specifically mentioned Ozempic, referring to it as "the fat loss drug" when asked about a $1 ...